Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-37,597
Closed -$5.15M 4639
2017
Q4
$5.15M Buy
37,597
+20,719
+123% +$2.74M 0.02% 799
2017
Q3
$2.19M Buy
16,878
+2,794
+20% +$373K 0.01% 1306
2017
Q2
$1.86M Buy
14,084
+7,216
+105% +$884K 0.01% 1402
2017
Q1
$846K Sell
6,868
-43,300
-86% -$5.13M 0.01% 1826
2016
Q4
$5.53M Buy
50,168
+20,835
+71% +$2.31M 0.04% 639
2016
Q3
$3.46M Buy
29,333
+12,688
+76% +$1.5M 0.03% 915
2016
Q2
$1.86M Sell
16,645
-17,344
-51% -$1.87M 0.01% 1297
2016
Q1
$3.42M Sell
33,989
-38,645
-53% -$3.71M 0.03% 832
2015
Q4
$7.71M Buy
72,634
+61,110
+530% +$6.3M 0.05% 486
2015
Q3
$1.07M Buy
11,524
+9,662
+519% +$999K 0.01% 2123
2015
Q2
$194K Sell
1,862
-5,355
-74% -$557K ﹤0.01% 3747
2015
Q1
$782K Buy
+7,217
New +$742K 0.01% 2138
2014
Q3
Sell
-1,164
Closed -$102K 4936
2014
Q2
$102K Sell
1,164
-4,423
-79% -$383K ﹤0.01% 3706
2014
Q1
$471K Buy
+5,587
New +$446K ﹤0.01% 2604

Other funds holding LH

PEAK6 Group's LH Position: Q4 2017 in Review

PEAK6 Group sold out of Labcorp (LH) in Q4 2017, closing a stake of 17 shares — an estimated $2.25K sold.

PEAK6 Group first reported a position in LH in Q2 2013 and held it in 11 quarters. The position peaked at $2.4M in Q4 2014. 753 funds tracked by Wall St. Rank hold LH as of Q4 2017.

  • PEAK6 Group reported no remaining Labcorp position as of Q4 2017 after selling out during the quarter.
  • PEAK6 Group sold 17 Labcorp shares in Q4 2017, an estimated $2.25K.
  • PEAK6 Group first reported a position in Labcorp in Q2 2013 and held it in 11 quarters.
  • PEAK6 Group's Labcorp position peaked at $2.4M in Q4 2014.
  • 753 funds tracked by Wall St. Rank held Labcorp as of Q4 2017.

Based on PEAK6 Group's 13F filing for Q4 2017, filed 14 Feb 2018.